Atrial myxoma: An approach from rehabilitation. Case report and literature review
DOI:
https://doi.org/10.28957/rcmfr.476Keywords:
Myxoma, cardiac rehabilitation, risk reduction behavior, ostoperative, xercise therapyAbstract
Introduction. Cardiac myxomas are rare benign tumors whose indicated treatment is surgical resection. They can generate alterations in the structure of the heart contributing to cardiac diseases. It is described as a disease of low mortality but with not documented morbidity.
Objectives. To carry out a literature review with the report of a clinical case of a patient with atrial myxoma and determine the possible impact of physical exercise and cardiac rehabilitation programs on morbidity and performance of patients with this type of tumors.
Case presentation. A 36-year-old male patient with a left atrial myxoma of large size which caused him progressive dyspnea, who underwent surgical resection of the tumor. Comprehensive cardiac rehabilitation was started in the late postoperative period through the prescripción of exercise, evaluation of his body composition and psychosocial follow-up.
Discussion. Cardiac myxoma is a condition which shares oncological and cardiovascular features grouping a structural cardiac alteration mediated by a process of cell replication, cell migration and unregulated chronic inflammation, for which its morbidity can be high. Therefore, from the theoretical viewpoint, cardiac rehabilitation programs could have positive effects on patients with these tumors.
Conclusion. Cardiac rehabilitation programs can be very useful to reduce morbidity and improve quality of life and functional performance of patients with cardiac myxomas; however, this approach needs to be investígated and contrasted with evidence-based medicine.
References
Li X, Chen Y, Liu J, Xu L, Li Y, Liu D, et al. Cardiac magnetic resonance imaging of primary cardiac tumors. Quant Imaging Med Surg. 2020;10(1):294-313. Disponible en: https://doi.org/10.21037/qims.2019.11.13.
Velez-Torres JM, Martínez-Duarte E, Diaz-Perez JA, Rosenberg AE. Cardiac Myxoma: Review and Update of Contemporary Immunohistochemical Markers and Molecular Pathology. Adv Anat Pathol. 2020;27(6):380-4. Disponible en: https://doi.org/10.1097/PAP.0000000000000275.
Chatzikonstantinou S, Kazis D, Giannakopoulou P, Poulios P, Pikou O, Geroukis T, et al. Carney complex syndrome manifesting as cardioembolic stroke: a case report and review of the literature. Int J Neurosci. 2022;132(7):649-55. Disponible en: https://doi.org/10.1080/00207454.2020.1834393.
Pitsava G, Stratakis CA, Faucz FR. PRKAR1A and Thyroid Tumors. Cancers (Basel). 2021;13(15):3834. Disponible en: https://doi.org/10.3390/cancers13153834.
Sankarasubramanian S, Prabhakar P, Narasimhan MK. Genetic insights into cardiac tumors: a comprehensive review. Med Oncol. 2022;39(11):164. Disponible en: https://doi.org/10.1007/s12032-022-01761-5.
Islam AKMM. Cardiac myxomas: A narrative review. World J Cardiol. 2022;14(4):206-19. Disponible en: https://doi.org/10.4330/wjc.v14.i4.206.
Presta I, Donato A, Chirchiglia D, Malara N, Donato G. Cardiac myxoma and neural crests: a tense relationship. Cardiovasc Pahol. 2019;44:107163. Disponible en: https://doi.org/10.1016/j.carpath.2019.107163.
McAllister BJ. Multi modality imaging features of cardiac myxoma. J Cardiovasc Imaging. 2020;28(4):235-43. Disponible en: https://doi.org/10.4250/jcvi.2020.0027.
Pirola S, Fiori S, Maffini F, Mostardini G, Mastroiacovo G, Polvani G. A Malignant Lymphoma Growing Inside a Cardiac Mixoma: A Case Report. Braz J Cardiovasc Surg. 2022;37(3):412-6. Disponible en: https://doi.org/10.21470/1678-9741-2021-0081.
Corin J, Carlsson A, Peters B. Right atrial myxoma as the first manifestation of granulomatosis with polyangiitis, and a possible association with vascular endothelial growth factor (VEGF) and interleukin 6 (IL-6): a case report and review of the literature. Eur J Med Res. 2022;27(1):4. Disponible en: https://doi.org/10.1186/s40001-022-00632-z.
Chojdak-Łukasiewicz J, Budrewicz S, Waliszewska-Prosół M. Cerebral Aneurysms Caused by Atrial Myxoma—A Systematic Review of the Literature. J Pers Med. 2022;13(1):8. Disponible en: https://doi.org/10.3390/jpm13010008.
Cho J, Quach S, Reed J, Osian O. Case report: Left atrial Myxoma causing elevated C-reactive protein, fatigue and fever, with literature review. BMC Cardiovasc Disord. 2020;20(1):119. Disponible en: https://doi.org/10.1186/s12872-020-01397-1.
Mustafa ER, Tudoraşcu DR, Giucă A, Toader DM, Foarfă MC, Puiu I, et al. A rare cause of ischemic stroke: cardiac myxoma. Case report and review of literature. Rom J Morphol Embryol. 2018;59(3):903-9.
Thyagarajan B, Kumar MP, Patel S, Agrawal A. Extracardiac manifestations of atrial myxomas. J Saudi Heart Assoc. 2017;29(1):37-43. Disponible en: http://dx.doi.org/10.1016/j.jsha.2016.07.003.
Allen PW. Myxoma Is Not a Single Entity: A Review of the Concept of Myxoma. Ann Diagn Pathol. 2000;4(2):99-123. Disponible en: https://doi.org/10.1016/s1092-9134(00)90019-4.
Aguilar C, Carbajal T, Beltran BE, Segura P, Muhammad S, Choque-Velasquez J. Cerebral embolization associated with parenchymal seeding of the left atrial myxoma: Potential role of interleukin-6 and matrix metalloproteinases. Neuropathology. 2021;41(1):49-57. Disponible en: https://doi.org/10.1111/neup.12697.
Jaravaza DR, Lalla U, Zaharie SD, de Jager LJ. Unusual Presentation of Atrial Myxoma: A Case Report and Review of the Literature. Am J Case Rep. 2021;22:e931437. Disponible en: https://doi.org/10.12659/AJCR.931437.
Inserra MC, Cannizzaro MT, Passaniti G, Celona A, Secinaro A, Curione D, et al. MR imaging of primary benign cardiac tumors in the pediatric population. 2023;9(9):e19932. Disponible en: https://doi.org/10.1016/j.heliyon.2023.e19932.
Tyebally S, Chen D, Bhattacharyya S, Mughrabi A, Hussain Z, Manisty C, et al. Cardiac Tumors: JACC CardioOncology State-of-the-Art Review. 2020;2(2):293-311. Disponible en: https://doi.org/10.1016/j.jaccao.2020.05.009.
Bussani R, Castrichini M, Restivo L, Fabris E, Porcari A, Ferro F, et al. Cardiac Tumors: Diagnosis, Prognosis, and Treatment. Curr Cardiol Rep. 2020;22(12):169. Disponible en: https://doi.org/10.1007/s11886-020-01420-z.
Li Y, Yang W, Liao S, Zuo H, Liu M. Cardiac myxomas as great imitators: A rare case series and review of the literature. Heart Lung. 2022;52:182-9. Disponible en: https://doi.org/10.1016/j.hrtlng.2022.01.010.
Saputra PBT, Jannah AR, Rofananda IF, Al-Farabi MJ, Wungu CDK, Susilo H, et al. Clinical characteristics, management, and outcomes of pulmonary valve myxoma: systematic review of published case reports. World J Surg Oncol. 2023;21(1):99. Disponible en: https://doi.org/10.1186/s12957-023-02984-0.
de Boer RA, Aboumsallem JP, Bracun V, Leedy D, Cheng R, Patel S, et al. A new classification of cardio-oncology syndromes. CardioOncology. 2021;7(1):24. Disponible en: https://doi.org/10.1186/s40959-021-00110-1.
Gilchrist SC, Barac A, Ades PA, Alfano CM, Franklin BA, Jones LW, et al. Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement from the American Heart Association. Circulation. 2019;139(21):e997-1012. Disponible en: https://doi.org/10.1161/CIR.0000000000000679.
Karlstaedt A, Barrett M, Hu R, Gammons ST, Ky B. Cardio-Oncology: Understanding the Intersections Between Cardiac Metabolism and Cancer Biology. JACC Basic Transl Sci. 2021;6(8):705-18. Disponible en: https://doi.org/10.1016/j.jacbts.2021.05.008.
Oktaviono YH, Saputra PBT, Arnindita JN, Afgriyuspita LS, Kurniawan RB, Pasahari D, et al. Clinical characteristics and surgical outcomes of cardiac myxoma: A meta-analysis of worldwide experience. Eur J Surg Oncol. 2024;50(2):107940. Disponible en: https://doi.org/10.1016/j.ejso.2023.107940.
Cheville A, Smith S, Barksdale T, Asher A. Cancer Rehabilitation. In: Cifu DX, editor. Braddom’s Physical Medicine and Rehabilitation. Elsevier Inc.; 2020. p. 568-593.e7. Disponible en: https://doi.org/10.1016/B978-0-323-62539-5.00029-1.
Alvarado-Castro C, Vega-Brizneda MP, Matijasevic-Arcila E, Maldonado-Escalante JD, Buitrago-Sandoval A. Mixoma ventricular izquierdo. Rev Colomb Cardiol. 2017;24(3):300.e1-5. Disponible en: http://dx.doi.org/10.1016/j.rccar.2016.08.007.
Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2017;35(8):893-911. Disponible en: https://doi.org/10.1200/JCO.2016.70.5400.
Wittekind SG, Gilchrist SC. Exercise testing and cardiac rehabilitation in patients treated for cancer. J Thromb Thrombolysis. 2021;51(4):870-6. Disponible en: https://doi.org/10.1007/s11239-020-02265-7.
Vásquez Rojas MF, Rodríguez Mojica YM, Moreno Capacho MM, Palomino Ariza GA. Rehabilitación oncológica en cardiotoxicidad: rompiendo paradigmas en la atención al sobreviviente de cáncer. Rev. Colomb. Med. Fis. Rehab. 2021;31(1):58-72. Disponible en: https://doi.org/10.28957/rcmfr.v31n1a7.
Pituskin E, Foulkes SJ, Cox-Kennett N, Driga A, Dimitry R, Thompson RB, et al. Cardio-oncology and Cancer Rehabilitation: Is an Integrated Approach Possible? Can J Cardiol. 2023;39(Suppl 11):S315-22. Disponible en: https://doi.org/10.1016/j.cjca.2023.09.024.
Vudatha V, Devarakonda T, Liu C, Freudenberger DC, Riner AN, Herremans KM, et al. Review of Mechanisms and Treatment of Cancer-Induced Cardiac Cachexia. Cells. 2022;11(6):1040. Disponible en: https://doi.org/10.3390/cells11061040.
Stubblefield M, O’dell M. Cancer Rehabilitation principles and practice. New York: Demos Medical Publishing; 2009.
Squires RW, Bonikowske AR. Cardiac rehabilitation for heart transplant patients: Considerations for exercise training. Prog Cardiovasc Dis. 2022;70:40-8. Disponible en: https://doi.org/10.1016/j.pcad.2021.12.003.
Pedersen BK, Saltin B. Exercise as medicine - Evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25(Suppl 3):1-72. Disponible en: https://doi.org/10.1111/sms.12581.
Pushparaji B, Donisan T, Balanescu DV, Palaskas N, Kim P, Lopez-Mattei J, et al. Interventional Strategies in Cancer-induced Cardiovascular Disease. Curr Oncol Rep. 2021;23(11):133. Disponible en: https://doi.org/10.1007/s11912-021-01113-y.
Kourek C, Karatzanos E, Nanas S, Karabinis A, Dimopoulos S. Exercise training in heart transplantation. World J Transplant. 2021;11(11):466-79. Disponible en: https://doi.org/10.5500/wjt.v11.i11.466.
Wernhart S, Rassaf T. Relevance of Cardiovascular Exercise in Cancer and Cancer Therapy-Related Cardiac Dysfunction. Curr Heart Fail Rep. 2024;21(3):238-51. Disponible en: https://doi.org/10.1007/s11897-024-00662-0.
Ramos-dos Santos PM, Aquaroni-Ricci N, Aparecida-Bordignon Suster, de Moraes-Paisani D, Días-Chiavegato L. Effects of early mobilisation in patients after cardiac surgery: a systematic review. Physiotherapy. 2017;103(1):1-12. Disponible en: https://doi.org/10.1016/j.physio.2016.08.003.
Borges MGB, Borges DL, Ribeiro MO, Lima LSS, Macedo KCM, Nina VJDS. Early Mobilization Prescription in Patients Undergoing Cardiac Surgery: Systematic Review. Braz J Cardiovasc Surg. 2022;37(2):227-38. Disponible en: https://doi.org/10.21470/1678-9741-2021-0140.
Nasrawi D, Latimer S, Massey D, Gillespie BM. Delivery, barriers, and enablers to patient participation in inpatient cardiac rehabilitation following cardiac surgery: An integrative review. Aust Crit Care. 2023;36(3):420-30. Disponible en: https://doi.org/10.1016/j.aucc.2022.01.007.
Coma N, Moral S, Ballesteros E, Eraso A, Ventura M, Pujol E, et al. Current Evidence on the Benefit of Exercise in Cancer Patients: Effects on Cardiovascular Mortality, Cardiotoxicity, and Quality of Life. Rev Cardiovasc Med. 2023;24(6):160. Disponible en: https://doi.org/10.31083/j.rcm2406160.
Mamataz T, Uddin J, Ibn Alam S, Taylor RS, Pakosh M, Grace SL. Effects of cardiac rehabilitation in low-and middle-income countries: A systematic review and meta-analysis of randomised controlled trials. Prog Cardiovasc Dis. 2022;70:119-74. Disponible en: https://doi.org/10.1016/j.pcad.2021.07.004.
Dibben GO, Faulkner J, Oldridge N, Rees K, Thompson DR, Zwisler AD, et al. Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis. Eur Heart J. 2023;44(6):452-69. Disponible en: https://doi.org/10.1093/eurheartj/ehac747.
Brown SA. Preventive Cardio-Oncology: The Time Has Come. Front Cardiovasc Med. 2020;6:187. Disponible en: https://doi.org/10.3389/fcvm.2019.00187.
Zoth N, Tomanek A, Seuthe K, Pfister R, Baumann FT. Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review. Oncol Res Treat. 2023;46(4):131-9. Disponible en: https://doi.org/10.1159/000529205.
Vu T, Smith JA. The pathophysiology and management of depression in cardiac surgery patients. Front Psychiatry. 2023;14:1195028. Disponible en: https://doi.org/10.3389/fpsyt.2023.1195028.
Bisceglia I, Canale ML, Silvestris N, Gallucci G, Camerini A, Inno A, et al. Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals. Front Cardiovasc Med. 2023;10:1223660. Disponible en: https://doi.org/10.3389/fcvm.2023.1223660.
Caldonazo T, Kirov H, Rahouma M, Robinson NB, Demetres M, Gaudino M, et al. Atrial fibrillation after cardiac surgery: A systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2023;165(1):94-103.e24. Disponible en: https://doi.org/10.1016/j.jtcvs.2021.03.077.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Revista Colombiana de Medicina Física y Rehabilitación
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
